Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,158 | 67 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $298.09 | 22 | $0 (2023) |
| Evoke Pharma, Inc. | $178.44 | 5 | $0 (2022) |
| ABBVIE INC. | $136.34 | 7 | $0 (2024) |
| Lilly USA, LLC | $119.26 | 7 | $0 (2024) |
| Novo Nordisk Inc | $81.05 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $56.84 | 4 | $0 (2023) |
| PFIZER INC. | $55.30 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $50.43 | 3 | $0 (2024) |
| Amgen Inc. | $46.99 | 3 | $0 (2021) |
| Axsome Therapeutics, Inc. | $41.82 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $227.32 | 12 | Lilly USA, LLC ($66.79) |
| 2023 | $211.09 | 12 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($43.13) |
| 2022 | $347.67 | 15 | Evoke Pharma, Inc. ($160.98) |
| 2021 | $372.15 | 28 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($219.20) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Obesity | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Obesity | ||||||
| 07/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: WOMENS HEALTH | ||||||
| 02/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Obesity | ||||||
| 01/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Diabetes | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Gastroenterology | ||||||
| 08/28/2023 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE QUADRIVALENT NORTHERN HEMISPHERE, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Vaccines | ||||||
| 08/24/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: INSOMNIA | ||||||
| 08/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Diabetes | ||||||
| 08/11/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Obesity | ||||||
| 07/11/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: WOMENS HEALTH | ||||||
| 06/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/04/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Respiratory | ||||||
| 02/23/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Neurology | ||||||
| 01/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Gastroenterology | ||||||
| 01/10/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Neurology | ||||||
| 12/13/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 363 | 510 | $45,540 | $16,002 |
| 2022 | 16 | 568 | 798 | $83,755 | $31,346 |
| 2021 | 11 | 344 | 423 | $44,560 | $17,390 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 181 | $19,870 | $8,450 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 32 | $4,640 | $1,594 | 34.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $3,120 | $1,555 | 49.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 37 | $2,775 | $1,492 | 53.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 21 | 21 | $5,250 | $667.08 | 12.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 19 | 19 | $1,140 | $522.18 | 45.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 46 | 60 | $2,660 | $504.00 | 18.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 14 | 15 | $705.00 | $255.72 | 36.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 24 | 24 | $1,320 | $238.05 | 18.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 18 | 18 | $810.00 | $223.04 | 27.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 26 | $780.00 | $216.72 | 27.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 22 | 22 | $1,320 | $159.81 | 12.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 14 | $700.00 | $73.00 | 10.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 15 | $450.00 | $51.15 | 11.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 137 | 256 | $28,130 | $13,397 | 47.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 72 | 72 | $8,640 | $5,590 | 64.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 92 | 99 | $24,750 | $3,355 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 38 | $5,510 | $2,977 | 54.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $1,800 | $1,449 | 80.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 23 | 23 | $2,070 | $1,269 | 61.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 37 | 75 | $4,125 | $1,188 | 28.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 24 | 25 | $2,035 | $892.53 | 43.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 19 | 26 | $1,310 | $383.17 | 29.2% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 19 | 20 | $900.00 | $357.70 | 39.7% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 12 | 20 | $700.00 | $163.16 | 23.3% |
About Deborah Weese, APRN, FNP-C
Deborah Weese, APRN, FNP-C is a Family healthcare provider based in Hudson, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2019. The National Provider Identifier (NPI) number assigned to this provider is 1952958860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Deborah Weese, APRN, FNP-C has received a total of $1,158 in payments from pharmaceutical and medical device companies, with $227.32 received in 2024. These payments were reported across 67 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,158).
As a Medicare-enrolled provider, Weese has provided services to 1,275 Medicare beneficiaries, totaling 1,731 services with total Medicare billing of $64,738. Data is available for 3 years (2021–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Hudson, OH
- Active Since 08/26/2019
- Last Updated 08/26/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1952958860
Products in Payments
- XIFAXAN (Drug) $298.09
- GIMOTI (Drug) $178.44
- MOUNJARO (Drug) $79.64
- UBRELVY (Drug) $74.19
- Wegovy (Drug) $68.67
- XARELTO (Drug) $56.84
- Aimovig (Biological) $46.99
- QULIPTA (Drug) $45.67
- Sunosi (Drug) $41.82
- PREMARIN (Drug) $39.48
- TRULICITY (Drug) $25.46
- AIRSUPRA (Drug) $23.99
- Zubsolv (Drug) $21.94
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $21.83
- TRELEGY ELLIPTA (Drug) $19.82
- VRAYLAR (Drug) $16.48
- COLOGUARD DNA CAPTURE REAGENTS (Device) $15.82
- QUVIVIQ (Drug) $15.07
- JARDIANCE (Drug) $14.16
- BREZTRI (Drug) $13.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Hudson
Mrs. Tayler Yoder, C.n.p, C.N.P
Family — Payments: $7,132
Marilyn Miller, Np, NP
Family — Payments: $4,833
Mr. Adam Murchie, Arnp, ARNP
Family — Payments: $4,547
Mrs. Ashley Carver, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $3,706
Kristin Magnanini, N.p, N.P
Family — Payments: $3,683
Catherine Hare, Np, NP
Family — Payments: $2,479